| ATF3 | activating transcription factor 3 |
| ATP | adenosine triphosphate |
| BMP-2 | bone morphogenetic protein-2 |
| CGRP | calcitonin gene-related peptide |
| DAT | deep adipose tissue |
| EFD | energy flux density |
| eNOS | endothelial nitric oxide synthase |
| ERK; Erk1/2 | extracellular-signal-regulated kinase |
| ESWT | extracorporeal shock wave therapy |
| FAK | focal adhesion kinase |
| fESWT | focused shock wave therapy |
| FNEs | free nerve endings |
| fSW | focused shock waves |
| GSK-3β | glycogen synthase kinase 3 beta |
| HA | hyaluronic acid |
| HMW | high-molecular-weight |
| IGF-I | insulin-like growth factor-I |
| MNT | mechanical nociceptive threshold |
| MPa | megaPascal |
| MPS | myofascial pain syndrome |
| MTrPs | myofascial trigger points |
| PAG | periaqueductal grey |
| PCNA | proliferating cell nuclear antigen |
| PERK | protein kinase R-like endoplasmic reticulum kinase |
| PF | plantar fasciitis |
| PTLF | posterior layer of the thoracolumbar fascia |
| RCTs | randomized controlled trials |
| rESWT | radial shock wave therapy |
| rSW | radial shock waves |
| SAT | superficial adipose tissue |
| SP | substance P |
| TGF-β1 | transforming growth factor-beta 1 |
| TLF | thoracolumbar fascia |
| TLR3 | toll-like receptor 3 |
| TRPV1 | transient receptor potential cation channel subfamily V member 1 |
| VAS | visual analog scale |
| VEGF | vascular endothelial growth factor |